Vida Ventures

Vida Ventures accounts for 25 tracked companies with verified cap-table data, 25 of which disclose round sizes totalling $4.6B. The median disclosed raise is $165M, and the largest is ReCode Therapeutics at $570M, ahead of Cullinan Oncology ($499M) and Hexagon Bio ($323M).

The names that recur most often on these portfolio cap tables are Vida Ventures (25 companies), Polaris Partners (7 companies), OrbiMed (5 companies), The Column Group (4 companies), Nextech Invest (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (10), Series B (4), Series C (4), Seed (3).

• Companies tracked: 25
• Disclosed funding total: $4.6B across 25 companies
• Median disclosed raise: $165M
• Largest raise: ReCode Therapeutics — $570M
• Stage mix: Series A 10 · Series B 4 · Series C 4 · Seed 3
• Most recent dated round: 2026-03-01

Best funded Vida Ventures companies

1. ReCode Therapeutics — $570M (latest: Series B)
2. Cullinan Oncology — $499M (latest: IPO)
3. Hexagon Bio — $323M (latest: Series B)
4. Asklepios BioPharmaceutical — $235M (latest: Growth)
5. Alterome Therapeutics — $231M (latest: Series A)
6. Soufflé Therapeutics — $200M (latest: Series A)
7. PACT Pharma — $200M (latest: Series C)
8. Dyne Therapeutics — $200M (latest: Series E)
9. Kinnate Biopharma — $195M (latest: Series C)
10. Protego Biopharma — $181M (latest: Series B)
11. Antares Therapeutics — $177M (latest: Series A)
12. Affini-T Therapeutics — $175M (latest: Seed)
13. Capstan Therapeutics — $165M (latest: Series A)
14. Third Arc Bio — $165M (latest: Series A)
15. Quanta Therapeutics — $142M (latest: Series D)

Vida Ventures — related firms and companies (56)

• ReCode Therapeutics
• Cullinan Oncology
• Hexagon Bio
• Asklepios BioPharmaceutical
• Alterome Therapeutics
• Soufflé Therapeutics
• PACT Pharma
• Dyne Therapeutics
• Investors like Redpoint
• IconOVir Bio
• Investors like Slow Ventures
• Tectonic Therapeutic
• Investors like Bain Capital
• InduPro
• Investors like Sapphire Ventures
• Praxis Precision Medicines
• Investors like AME Cloud Ventures
• LB Pharmaceuticals
• Investors like Accomplice
• Quanta Therapeutics
• Investors like DCM Ventures
• Capstan Therapeutics
• Investors like Primary Venture Partners
• Antares Therapeutics
• Investors like Capital One Ventures
• Kinnate Biopharma
• Investors like Trinity Ventures
• Investors like QED Investors
• Investors like Thirdbase Capital
• Investors like Canapi Ventures
• Investors like Founders Fund
• Investors like Bienville Capital
• Companies backed by Vida Ventures
• Investors like Kleiner Perkins
• Vida Ventures co-investors 2026
• Investors like Google Ventures
• Pionyr Immunotherapeutics
• Investors like Correlation Ventures
• Volastra Therapeutics
• Investors like General Atlantic
• Poplar Therapeutics
• Investors like Venrock
• Kronos Bio
• Investors like RRE Ventures
• A2 Biotherapeutics
• Investors like Digital Currency Group
• Third Arc Bio
• Investors like F-Prime
• Affini-T Therapeutics
• Investors like boldstart ventures
• Protego Biopharma
• Investors like Recursive Ventures
• Investors like Amino Capital
• Investors like Coinbase
• Investors like SoftBank Vision Fund
• Investors like Blockchain Capital

Vida Ventures alternatives · All research reports